These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 6995791)
41. Correlation between the nature and amount of carbohydrate in meal intake and insulin delivery by the artificial pancreas in 24 insulin-dependent diabetics. Slama G; Klein JC; Delage A; Ardila E; Lemaignen H; Papoz L; Tchobroutsky G Diabetes; 1981 Feb; 30(2):101-5. PubMed ID: 7009264 [TBL] [Abstract][Full Text] [Related]
42. Pre- and postprandial hyperinsulinemia during insulin pump treatment; role of the subcutaneous bolus and basal infusion. Olsson PO; Jorfeldt L; Arnqvist H; Gerhardsson P Diabetes Res; 1991 Feb; 16(2):55-61. PubMed ID: 1817806 [TBL] [Abstract][Full Text] [Related]
43. Fasting and postprandial plasma glucose and peripheral insulin levels in insulin-dependent diabetes mellitus and non-insulin-dependent diabetes mellitus subjects during continuous intraperitoneal versus subcutaneous insulin delivery. Hermans MP; van Ypersele de Strihou M; Ketelslegers JM; Squifflet JP; Buysschaert M Transplant Proc; 1995 Dec; 27(6):3329-30. PubMed ID: 8539974 [No Abstract] [Full Text] [Related]
44. Subcutaneous versus intraperitoneal administration of insulin on post-prandial hyperglycaemia and glucose turnover in alloxan diabetic dogs. Rizza RA; Westland RE; Hall LD; Patton G; Haymond MW; Clemens AH; Gerich JE; Service FJ Diabetologia; 1982 Jul; 23(1):61-4. PubMed ID: 6749587 [TBL] [Abstract][Full Text] [Related]
45. Effect of diabetes mellitus and insulin on the turnover and metabolic response to ketones in man. Sherwin RS; Hendler RG; Felig P Diabetes; 1976 Sep; 25(9):776-84. PubMed ID: 955305 [TBL] [Abstract][Full Text] [Related]
46. Insulin-infusion-pump treatment of diabetes: influence of improved metabolic control on plasma somatomedin levels. Tamborlane WV; Hintz RL; Bergman M; Genel M; Felig P; Sherwin RS N Engl J Med; 1981 Aug; 305(6):303-7. PubMed ID: 7017416 [TBL] [Abstract][Full Text] [Related]
47. Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial. Haidar A; Legault L; Messier V; Mitre TM; Leroux C; Rabasa-Lhoret R Lancet Diabetes Endocrinol; 2015 Jan; 3(1):17-26. PubMed ID: 25434967 [TBL] [Abstract][Full Text] [Related]
48. SHBG (sex hormone binding globulin) levels in insulin dependent diabetic patients according to the route of insulin administration. Lassmann-Vague V; Raccah D; Pugeat M; Bautrant D; Belicar P; Vague P Horm Metab Res; 1994 Sep; 26(9):436-7. PubMed ID: 7835829 [No Abstract] [Full Text] [Related]
49. Practical aspects and considerations when switching between continuous subcutaneous insulin infusion and multiple daily injections. Meneghini L; Sparrow-Bodenmiller J Diabetes Technol Ther; 2010 Jun; 12 Suppl 1():S109-14. PubMed ID: 20515298 [TBL] [Abstract][Full Text] [Related]
50. Plasma lipid and lipoprotein levels with continuous subcutaneous insulin infusion in type I diabetes mellitus. Dunn FL; Pietri A; Raskin P Ann Intern Med; 1981 Oct; 95(4):426-31. PubMed ID: 7025720 [TBL] [Abstract][Full Text] [Related]
51. Reduction to normal of plasma glucose in juvenile diabetes by subcutaneous administration of insulin with a portable infusion pump. Tamborlane WV; Sherwin RS; Genel M; Felig P N Engl J Med; 1979 Mar; 300(11):573-8. PubMed ID: 763270 [TBL] [Abstract][Full Text] [Related]
52. Controlled drug delivery in the treatment of diabetes mellitus. Irsigler K; Kritz H; Lovett RG Crit Rev Ther Drug Carrier Syst; 1985; 1(3):189-280. PubMed ID: 3912064 [TBL] [Abstract][Full Text] [Related]
53. Control of hyperglycemia in adult diabetics by pulsed insulin delivery. Genuth S; Martin P Diabetes; 1977 Jun; 26(6):571-81. PubMed ID: 863127 [TBL] [Abstract][Full Text] [Related]
54. Continuous subcutaneous insulin infusion: comparison of plasma insulin profiles after infusion or bolus injection of the mealtime dose. Home PD; Pickup JC; Keen H; Alberti KG; Parsons JA; Binder C Metabolism; 1981 May; 30(5):439-42. PubMed ID: 6112654 [TBL] [Abstract][Full Text] [Related]
56. Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function. Pampanelli S; Torlone E; Ialli C; Del Sindaco P; Ciofetta M; Lepore M; Bartocci L; Brunetti P; Bolli GB Diabetes Care; 1995 Nov; 18(11):1452-9. PubMed ID: 8722069 [TBL] [Abstract][Full Text] [Related]
57. Outpatient treatment of juvenile-onset diabetes with a preprogrammed portable subcutaneous insulin infusion system. Tamborlane WV; Sherwin RS; Genel M; Felig P Am J Med; 1980 Feb; 68(2):190-6. PubMed ID: 6986766 [TBL] [Abstract][Full Text] [Related]
58. Normalization of plasma glucose of unstable diabetes: studies under ambulatory, fed conditions with pumped intravenous insulin. Service FJ J Lab Clin Med; 1978 Mar; 91(3):480-9. PubMed ID: 627751 [TBL] [Abstract][Full Text] [Related]
59. Intraperitoneal versus subcutaneous insulin in patients on nighttime IPD. Bargman JM Adv Perit Dial; 1994; 10():116-9. PubMed ID: 7999807 [TBL] [Abstract][Full Text] [Related]
60. Insulin responses to mixed meals: comparison of an artificial beta cell and normal beta cells. Horwitz DL Horm Metab Res Suppl; 1979; (8):68-71. PubMed ID: 395093 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]